Ben Tre Pharmaceutical JSC

Ben Tre Pharmaceutical JSC Interest Coverage

The Interest Coverage Ratio of Ben Tre Pharmaceutical JSC (DBT.VN) as of Oct 30, 2026 is 1.53. In the previous year, Interest Coverage Ratio was 1.52 — a change of 0.59% (higher).

Interest Coverage

1.53

YoY

0.59%

Last updated:

Interest Coverage Ratio of Ben Tre Pharmaceutical JSC is 2024 1.53 . Interest Coverage Ratio of Ben Tre Pharmaceutical JSC was 2023 1.52 . It decreases by 0.59% higher compared to the previous year.

The Ben Tre Pharmaceutical JSC Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2014
5.56 VND
Jan 1, 2015
0.21 VND
Jan 1, 2020
2.45 VND
Jan 1, 2021
0.87 VND
Jan 1, 2022
2.14 VND
Jan 1, 2023
1.52 VND
Jan 1, 2024
1.53 VND
The Ben Tre Pharmaceutical JSC Interest Coverage history
YEARInterest CoverageYoY
1.53+0.59%
1.52-28.80%
2.14+146.17%
0.87-64.63%
2.45+1,067.93%
0.21-96.22%
5.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ben Tre Pharmaceutical JSC Stock analysis

What does Ben Tre Pharmaceutical JSC do? Ben Tre Pharmaceutical JSC manufactures and distributes pharmaceutical products, including medicinal products through its subsidiaries. The company wholesales, imports, and exports pharmaceuticals, materials, chemicals, packagings, and biological products. It also retails drugs and trades supplements, medical equipment, supplies, and machinery. The firm rents commercial space for additional revenue. Its primary customers are healthcare providers, pharmacies, and medical institutions requiring pharmaceuticals and medical supplies. The company's revenue streams include pharmaceutical manufacturing, wholesale distribution, import/export services, retail drug sales, and commercial space rentals. Key segments are pharmaceuticals, medical equipment, and biological products. The firm serves healthcare sectors through its subsidiaries and direct retail channels. Revenue is generated from both domestic and international trade activities. Ben Tre Pharmaceutical JSC's products include pharmaceuticals, medicinal products, medical equipment, and supplements. The company's brands are not specified in the business description. It targets healthcare providers, pharmacies, and medical institutions as its main buyers. The firm's operations span manufacturing, distribution, retail, and commercial leasing within the pharmaceutical and medical sectors. Ben Tre Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ben Tre Pharmaceutical JSC stock

Interest Coverage Ratio of Ben Tre Pharmaceutical JSC is 1.53 in 2024.

Interest Coverage Ratio of Ben Tre Pharmaceutical JSC changed from 1.52 to 1.53, representing a 0.59% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Ben Tre Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Ben Tre Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Ben Tre Pharmaceutical JSC

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Ben Tre Pharmaceutical JSC